新股消息 | 博纳西亚递表港交所主板

Group 1 - The core viewpoint of the article is that Bonasia (Hangzhou) Pharmaceutical Technology Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with joint sponsors being Xingsheng International and ICBC International [1] - Bonasia is a clinical contract research organization (CRO) based in Hangzhou, China, focused on empowering innovative drug clinical research through digitalization [1] - The company's primary business involves providing clinical trial technical services to domestic and international pharmaceutical and biotechnology companies, aiming to accelerate the research and commercialization processes of chemical drugs and biological products [1]